4//SEC Filing
Bartushak Jaime 4
Accession 0001213900-20-030792
CIK 0001506251other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 4:07 PM ET
Size
12.7 KB
Accession
0001213900-20-030792
Insider Transaction Report
Form 4
Bartushak Jaime
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase Common Stock)
2020-10-06+125,000→ 125,000 totalExercise: $1.01Exp: 2030-10-06→ Common Stock (125,000 underlying)
Holdings
- 60,353
Common Stock
- 70,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.62Exp: 2028-09-04→ Common Stock (70,000 underlying) - 48,267
Stock Option (Right to Purchase Common Stock)
Exercise: $10.50Exp: 2026-07-06→ Common Stock (48,267 underlying) - 100,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.67Exp: 2029-10-08→ Common Stock (100,000 underlying) - 25,000
Stock Option (Right to Purchase Common Stock)
Exercise: $3.45Exp: 2027-09-15→ Common Stock (25,000 underlying)
Footnotes (5)
- [F1]The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date
- [F2]The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
- [F3]One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, September 4, 2018, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
- [F4]On September 15, 2017 the Reporting Person was granted a ten-year option to purchase 25,000 shares of common stock at an exercise price of $3.45 per share. The options vest as follows: 8,333 shares vest on September 13, 2018, and then 694 shares per month for the next 24 months.
- [F5]On July 6, 2016 the Reporting Person was granted a ten-year option to purchase 48,267 shares of common stock at an exercise price of $10.50 per share. The options vest as follows: 16,089 shares vest on July 7, 2017, and then 1,341 shares per month for the next 24 months.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001725077
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 4:07 PM ET
- Size
- 12.7 KB